Kythera Biopharmaceuticals discovers, develops and commercializes novel prescription products for the aesthetic medicine market.
KYTHERA Biopharmaceuticals, Inc., formerly known as AESTHERx, Inc., was founded in August 2005 and is a privately held biopharmaceutical company located north of Los Angeles in southern California.KYTHERA is focused on science and innovation in aesthetic medicine. This market is expanding rapidly driven by an aging population, increasing discretionary income, and an evolution of patient preference toward restorative and preventative care. The company uses the tools of biotechnology to develop prescription therapeutics for this emerging market.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 19, 2011 | Series D | $37.40M | 3 | Foley Ventures | — | Detail |
May 19, 2008 | Series C | $30M | 4 | Jafco Life Science | — | Detail |
Jul 24, 2006 | Series B | $30M | 2 | — | — | Detail |
Sep 16, 2005 | Seed | $1M | 1 | Versant Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Foley Ventures | Yes | Series D |
Jafco Life Science | Yes | Series C |
ARCH Venture Partners | — | Series D |
Versant Ventures | — | Series D |
Apothecary Capital | — | Series C |